Literature DB >> 9674012

Diffuse ocular metastases as an initial sign of metastatic lung cancer.

J A Shields1, C L Shields, R C Eagle, K Gündüz, B Lin.   

Abstract

A 68-year-old man with lung carcinoma and no systemic metastasis presented with a blind, painful right eye. Examination showed no perception of light in the affected eye, elevated intraocular pressure, marked epibulbar hyperemia, and a white placoid mass in the conjunctiva nasally. Although a cataract precluded a clear view of the fundus, ultrasonography disclosed a total retinal detachment and a diffuse thickening of the choroid. Metastatic carcinoma was suspected clinically and the eye was enucleated because of severe, intractable pain. Pathologic examination demonstrated extensively necrotic metastatic adenocarcinoma involving the conjunctiva, peripheral cornea, sclera, iris, ciliary body, choroid, optic nerve, subarachnoid space, and orbit. Metastatic disease usually affects a singular ocular tissue, and it is highly unusual for such widespread ocular involvement to be the first sign of systemic metastasis from a primary neoplasm.

Entities:  

Mesh:

Year:  1998        PMID: 9674012

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  4 in total

1.  Unilateral temporal haemianopia in a patient with non-small cell lung cancer: intraocular metastasis despite chemotherapy.

Authors:  Alexander Liu; Harman Saman; Pawan Pusalkar
Journal:  BMJ Case Rep       Date:  2011-07-28

2.  Ciliary body tumour as the presenting manifestation of metastatic non-small cell adenocarcinoma of lung.

Authors:  Nirupama Kasturi; Vempuluru Sai Vijitha; Meyyappan Devan Rajagopal; Rajesh Nachiappa Ganesh
Journal:  BMJ Case Rep       Date:  2018-06-27

3.  Conjunctival metastasis as an initial sign of small cell lung cancer.

Authors:  Afsun Sahin; Nilgun Yildirim; Deniz Goren Sahin; Hikmet Basmak; Mustafa Acikalin
Journal:  Case Rep Med       Date:  2014-10-23

4.  Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA.

Authors:  Qian-Min Ge; Yu-Ting Zou; Wen-Qing Shi; Yu-Qing Zhang; Biao Li; You-Lan Min; Qing Yuan; Yi Shao
Journal:  Cancer Manag Res       Date:  2020-03-10       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.